Designs of preoperative biomarkers trials in oncology: a systematic review of the literature.

about

Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkers Neoadjuvant Trials in ER+ Breast Cancer: A Tool for Acceleration of Drug Development and Discovery.

P2860

Q28069856-2522D596-3917-40FE-AD3B-F009F72291EB Q39299810-CC3582ED-A3AA-41A3-A2C0-E1C301BC09B0

P2860

Designs of preoperative biomarkers trials in oncology: a systematic review of the literature.

Item

http://www.wikidata.org/entity/Q38586993

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Designs of preoperative biomar ...... atic review of the literature.

@en

type

Item

label

Designs of preoperative biomar ...... atic review of the literature.

@en

prefLabel

Designs of preoperative biomar ...... atic review of the literature.

@en

P1476

Designs of preoperative biomar ...... matic review of the literature

@en

P2093

A R A Razak

http://www.w3.org/2001/XMLSchema#string

A Stathis

http://www.w3.org/2001/XMLSchema#string

C Le Tourneau

http://www.w3.org/2001/XMLSchema#string

M Alt

http://www.w3.org/2001/XMLSchema#string

M Kamal

http://www.w3.org/2001/XMLSchema#string

M Marous

http://www.w3.org/2001/XMLSchema#string

X Paoletti

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study.

A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancer.

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancer.

Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer.

A pilot study of preoperative gefitinib for early-stage lung cancer to assess intratumor drug concentration and pathways mediating primary resistance

Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial.

P304

2419-2428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDV378

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ivan Bieche

P577

2015-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282035854

http://www.w3.org/2001/XMLSchema#string

P698

26371283

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Designs of preoperative biomarkers trials in oncology: a systematic review of the literature.

about

P2860

P2860

Designs of preoperative biomarkers trials in oncology: a systematic review of the literature.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921